Background:
Subarachnoid
hemorrhage
(SAH)
is
characterized
by
intense
central
inflammation,
leading
to
substantial
post-hemorrhagic
complications
such
as
vasospasm
and
delayed
cerebral
ischemia.
Given
the
anti-inflammatory
effect
of
transcutaneous
auricular
vagus
nerve
stimulation
(taVNS)
its
ability
promote
brain
plasticity,
taVNS
has
emerged
a
promising
therapeutic
option
for
SAH
patients.
However,
effects
on
cardiovascular
dynamics
in
critically
ill
patients,
like
those
with
SAH,
have
not
yet
been
investigated.
association
between
cardiac
elevated
risk
poor
clinical
outcomes
after
it
essential
characterize
ensure
this
approach
safe
fragile
population.
Therefore,
study
assessed
impact
both
acute
repetitive
function.
Methods:
In
randomized
trial,
24
patients
were
assigned
either
treatment
or
sham
group.
During
their
stay
intensive
care
unit,
we
monitored
patient
electrocardiogram
readings
vital
signs.
We
compared
long-term
changes
heart
rate,
rate
variability
(HRV),
QT
interval,
blood
pressure
two
groups.
Additionally,
comparing
metrics
before,
during,
intervention.
also
explored
biomarkers
exhibiting
improvement.
Results:
found
that
did
significantly
alter
pressure,
intracranial
(ICP).
increased
overall
HRV
parasympathetic
activity
treatment.
The
increase
was
most
pronounced
from
2
4
days
initial
(Cohen’s
d
=
0.50).
Acutely,
peripheral
perfusion
index
without
affecting
corrected
ICP,
HRV.
post-treatment
elevation
more
who
experienced
decrease
than
one
point
modified
Rankin
Score
at
time
discharge.
Conclusions:
Our
induce
adverse
effects,
bradycardia
prolongation,
supporting
development
immunomodulatory
observed
may
serve
biomarker
could
derive
greater
benefit
Funding:
American
Association
Neurological
Surgeons
(ALH),
Aneurysm
AVM
Foundation
National
Institutes
Health
R01-EB026439,
P41-EB018783,
U24-NS109103,
R21-NS128307
(ECL,
PB),
McDonnell
Center
Systems
Neuroscience
Fondazione
Neurone
(PB).
Clinical
trial
number:
NCT04557618
.
Frontiers in Electronics,
Journal Year:
2025,
Volume and Issue:
6
Published: Feb. 6, 2025
Recent
advances
in
manufacturing
of
flexible
and
conformable
microelectronics
have
opened
opportunities
for
health
monitoring
disease
treatment.
Other
material
engineering
advances,
such
as
the
development
conductive,
skin-like
hydrogels,
liquid
metals,
electric
textiles,
piezoelectric
films
provide
safe
comfortable
means
interfacing
with
human
body.
Together,
these
enabled
design
bioelectronic
devices
integrated
multimodal
sensing
stimulation
capabilities
to
be
worn
nearly
anywhere
on
Of
particular
interest
here,
external
ear
(auricle)
offers
a
unique
opportunity
scalable
high
degree
usability
familiarity
given
broad
use
headphones.
This
review
article
discusses
recent
auricular
capable
physiological
biochemical
sensing,
cognitive
monitoring,
targeted
neuromodulation,
control
human-computer
interactions.
Stemming
from
this
foundation,
there
will
increased
growth
competition
research
advance
bioelectronics.
activity
lead
adoption
smart
headphone-style
by
patients
consumers
tracking
health,
treating
medical
conditions,
enhancing
Brain stimulation,
Journal Year:
2025,
Volume and Issue:
18(3), P. 975 - 986
Published: April 29, 2025
The
locus
coeruleus-norepinephrine
(LC-NE)
system
is
a
well-established
regulator
of
behavior,
yet
its
precise
role
remains
unclear.
Animal
studies
predominantly
support
"gain"
hypothesis,
suggesting
that
the
LC-NE
enhances
sensory
processing.
In
contrast,
human
have
proposed
an
alternative
"urgency"
postulating
primarily
accelerates
responses.
To
address
this
discrepancy,
we
administered
transcutaneous
vagus
nerve
stimulation
(tVNS)
in
two
experiments.
first
experiment
(n
=
22),
showed
4-s
tVNS
trains
reliably
induced
greater
pupil
dilation
compared
to
SHAM
condition,
indicating
increased
activity.
second
21),
applied
during
random
dot
motion
task
assess
impact
on
perceptual
decision-making.
improved
accuracy
without
affecting
reaction
times,
which
appears
inconsistent
with
hypothesis.
Exploratory
drift-diffusion
model
analyses
further
revealing
drift
rate,
indicative
enhanced
evidence
accumulation.
Both
and
drift-rate
improvements
were
most
prominent
following
errors
especially
pronounced
participants
who
exhibited
post-error
declines
these
measures
under
SHAM.
Our
findings
align
tentative
activity
adapts
demands.
Accordingly,
strongest
effects
contexts
prone
declines,
possibly
reflecting
attentional
disengagement,
points
LC
mitigating
lapses
attention.
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(5), P. e0315606 - e0315606
Published: May 9, 2025
Background
:
Up
to
80%
of
patients
who
develop
coronavirus
disease-2019
(Covid-19)
infection
subsequently
experience
long
covid/post-covid
syndrome.
The
World
Health
Organization
(WHO)
has
estimated
that
>770
million
have
been
infected
with
Covid-19
globally.
Even
if
only
10%
these
covid,
>
75
will
suffer
for
a
period.
Among
the
various
symptoms
post-covid
syndrome,
fatigue
is
common,
affecting
up
60%
patients.
As
observed
in
other
viral
infections,
elevated
levels
inflammatory
cytokines
may
play
role.
Transcutaneous
auricular
vagal
nerve
stimulation
(taVNS)
noninvasive
method
modulates
immune
system
via
central
nervous
and
shown
promising
effects
autoimmune
diseases
improving
fatigue.
In
this
pilot
study,
we
investigated
feasibility
daily
taVNS
covid-related
Additionally,
on
quality
life
be
analyzed.
Methods
A
total
45
adult
covid
associated
syndrome
enrolled
randomized
above-threshold-stimulation,
below-threshold-stimulation,
or
sham-stimulation
arms,
after
being
informed
they
feel
stimulation.
above-threshold-group
receive
4-week-long
left-sided
cymba
conchae
25
Hz,
250
µs
pulse
width
28s/32s
on/off
paradigm
4
h
throughout
day.
below-threshold
group
below
sensational
threshold,
whereas
sham
no
following
application
non-functional
electrode.
protocol
recorded
either
manually
using
provided
app.
Three
well-established
questionnaires,
Multidimensional-Fatigue-Inventory-20,
Short-Form-36,
Beck-Depression-Inventory,
newly
established
Post-Covid-Syndrome-Score
completed
both
before
weeks
Discussion
primary
endpoint
set
as
patients’
average
time
weeks,
while
secondary
endpoints
include
Quality
Live
(QoL).
non-invasive
treatment
option,
notable
alternative
related
Trial
registration
This
study
was
approved
by
local
ethics
committee
(23/7798)
registered
(DRKS00031974)
(see
supporting
information
files).
Ethics
&
Dissemination:
ethical
justifiability
supported
prior
research
demonstrating
safety
taVNS.
Patients
recruited
general
practitioners,
written
consent
obtained.
All
data
pseudonymized
collection
storage.
results
published
peer-reviewed
journals
aim
providing
evidence
potential
management.
conducted
accordance
principles
Declaration
Helsinki.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 3, 2024
Subarachnoid
hemorrhage
(SAH)
is
characterized
by
intense
central
inflammation,
leading
to
substantial
post-hemorrhagic
complications
such
as
vasospasm
and
delayed
cerebral
ischemia.
Given
the
anti-inflammatory
effect
of
transcutaneous
auricular
vagus
nerve
stimulation
(taVNS)
its
ability
promote
brain
plasticity,
taVNS
has
emerged
a
promising
therapeutic
option
for
SAH
patients.
However,
effects
on
cardiovascular
dynamics
in
critically
ill
patients,
like
those
with
SAH,
have
not
yet
been
investigated.
association
between
cardiac
elevated
risk
poor
clinical
outcomes
after
it
essential
characterize
ensure
this
approach
safe
fragile
population.
Therefore,
we
assessed
impact
both
acute
repetitive
function
study.
Frontiers in Neuroscience,
Journal Year:
2024,
Volume and Issue:
18
Published: Dec. 4, 2024
Attention
deficit
hyperactivity
disorder
(ADHD)
is
a
neurodevelopmental
characterized
by
developmental
impairments,
inattention,
motor
hyperactivity,
and
impulsivity.
Currently,
there
no
effective
intervention
that
can
completely
cure
it.
One
of
the
pathogenic
mechanisms
ADHD
involves
abnormalities
in
norepinephrine
(NE)
pathway
within
prefrontal
cortex
(PFC).
In
recent
years,
transcutaneous
auricular
vagus
nerve
stimulation
(taVNS),
non-invasive
neuromodulation
technique,
has
demonstrated
promising
potential
treatment
neurological
psychiatric
disorders.
However,
its
application
management
remains
relatively
unexplored.
Previous
studies
have
shown
taVNS
exerts
therapeutic
effects
on
attention,
cognition,
arousal,
perception,
behavioral
regulation
primarily
through
activating
conduction
pathway,
specifically
targeting
nucleus
tractus
solitarius
-
locus
coeruleus
NE
pathway.
These
findings
led
to
hypothesis
may
be
an
for
ADHD,
with
playing
pivotal
role
this
context.
Therefore,
review
comprehensively
examines
correlation
between
alterations
PFC
mechanism
action
taVNS,
treating
aiming
provide
theoretical
foundation
clinical
applications.
Background:
Subarachnoid
hemorrhage
(SAH)
is
characterized
by
intense
central
inflammation,
leading
to
substantial
post-hemorrhagic
complications
such
as
vasospasm
and
delayed
cerebral
ischemia.
Given
the
anti-inflammatory
effect
of
transcutaneous
auricular
vagus
nerve
stimulation
(taVNS)
its
ability
promote
brain
plasticity,
taVNS
has
emerged
a
promising
therapeutic
option
for
SAH
patients.
However,
effects
on
cardiovascular
dynamics
in
critically
ill
patients,
like
those
with
SAH,
have
not
yet
been
investigated.
association
between
cardiac
elevated
risk
poor
clinical
outcomes
after
it
essential
characterize
ensure
this
approach
safe
fragile
population.
Therefore,
study
assessed
impact
both
acute
repetitive
function.
Methods:
In
randomized
trial,
24
patients
were
assigned
either
treatment
or
sham
group.
During
their
stay
intensive
care
unit,
we
monitored
patient
electrocardiogram
readings
vital
signs.
We
compared
long-term
changes
heart
rate,
rate
variability
(HRV),
QT
interval,
blood
pressure
two
groups.
Additionally,
comparing
metrics
before,
during,
intervention.
also
explored
biomarkers
exhibiting
improvement.
Results:
found
that
did
significantly
alter
pressure,
intracranial
(ICP).
increased
overall
HRV
parasympathetic
activity
treatment.
The
increase
was
most
pronounced
from
2
4
days
initial
(Cohen’s
d
=
0.50).
Acutely,
peripheral
perfusion
index
without
affecting
corrected
ICP,
HRV.
post-treatment
elevation
more
who
experienced
decrease
than
one
point
modified
Rankin
Score
at
time
discharge.
Conclusions:
Our
induce
adverse
effects,
bradycardia
prolongation,
supporting
development
immunomodulatory
observed
may
serve
biomarker
could
derive
greater
benefit
Funding:
American
Association
Neurological
Surgeons
(ALH),
Aneurysm
AVM
Foundation
National
Institutes
Health
R01-EB026439,
P41-EB018783,
U24-NS109103,
R21-NS128307
(ECL,
PB),
McDonnell
Center
Systems
Neuroscience
Fondazione
Neurone
(PB).
Clinical
trial
number:
NCT04557618
.
Subarachnoid
hemorrhage
(SAH)
is
characterized
by
intense
central
inflammation,
leading
to
substantial
post-hemorrhagic
complications
such
as
vasospasm
and
delayed
cerebral
ischemia.
Given
the
anti-inflammatory
effect
of
transcutaneous
auricular
vagus
nerve
stimulation
(taVNS)
its
ability
promote
brain
plasticity,
taVNS
has
emerged
a
promising
therapeutic
option
for
SAH
patients.
3,10,13
However,
effects
on
cardiovascular
dynamics
in
critically
ill
patients
like
those
with
have
not
yet
been
investigated.
association
between
cardiac
elevated
risk
poor
clinical
outcomes
after
SAH,
it
essential
characterize
ensure
this
approach
safe
fragile
population
5
.
Therefore,
we
assessed
impact
both
acute
repetitive
function
study.In
randomized
trial,
24
were
assigned
either
treatment
or
Sham
group.
During
their
stay
intensive
care
unit,
monitored
patient
electrocardiogram
(ECG)
readings
vital
signs.
We
compared
long-term
changes
heart
rate,
rate
variability,
QT
interval,
blood
pressure
two
groups.
Additionally,
comparing
metrics
before,
during,
intervention.
also
explored
rapidly
responsive
biomarkers
exhibiting
improvement.We
found
that
did
significantly
alter
corrected
pressure,
intracranial
pressure.
increased
overall
variability
parasympathetic
activity
from
5–10
days
initial
treatment,
sham
treatment.
Acutely,
peripheral
perfusion
index
without
affecting
variability.
The
post-treatment
elevation
was
more
pronounced
who
experienced
decrease
than
1
point
Modified
Rankin
Score
at
time
discharge.Our
study
induce
adverse
effects,
bradycardia
prolongation,
supporting
development
immunomodulatory
observed
increase
may
serve
biomarker
could
derive
greater
benefit
treatment.Trial
registration:
NCT04557618
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 14, 2024
Abstract
Vibration
offers
a
potential
alternative
modality
for
transcutaneous
auricular
vagus
nerve
stimulation
(taVNS).
However,
mechanisms
of
action
are
not
well-defined.
The
goal
this
study
was
to
evaluate
the
vibrotactile
as
method
activating
central
brain
regions
akin
other
vagal
methodologies.
To
do
so,
intracranial
electrophysiological
signals
were
recorded
in
human
subjects
perform
parametric
characterization
taVNS
and
investigate
changes
coherence
across
key
regions.
We
hypothesized
that
would
increase
between
limbic
areas,
similar
areas
activated
by
classic
electrical
VNS
approaches.
Our
specific
interest
included
orbitofrontal
cortex,
anterior
cingulate
amygdala,
hippocampus,
parahippocampal
gyrus.
Patients
with
intractable
epilepsy
undergoing
stereotactic
electroencephalography
(sEEG)
monitoring
participated
study.
Vibrotactile
administered
five
vibration
frequencies
following
randomized
on/off
pattern,
sEEG
throughout.
Spectral
response
defined
four
canonical
frequency
bands,
theta,
alpha,
beta,
broadband
gamma.
At
group
level,
resulted
significantly
increased
global
low-frequency
coherence.
Anatomically,
multiple
exhibited
notably
during
compared
baseline.
percentage
total
electrode
pairs
demonstrating
also
quantified
at
individual
level.
20
Hz
highest
responder
measures,
but
notable
inter-subject
variability
present.
Overall,
induced
significant
increases
involving
several
system
structures.
Further,
revealed
presence
terms
identifying
optimal
frequency.
These
findings
encourage
continued
research
into
an
noninvasive
stimulation.
Abstract
The
locus
coeruleus-norepinephrine
(LC-NE)
system
is
a
well-established
regulator
of
behavior,
yet
its
precise
role
remains
unclear.
Animal
studies
predominantly
support
“gain”
hypothesis,
suggesting
that
the
LC-NE
enhances
sensory
processing,
while
human
have
proposed
an
alternative
“urgency”
postulating
primarily
accelerates
responses.
To
address
this
discrepancy,
we
administered
transcutaneous
vagus
nerve
stimulation
(tVNS)
in
two
experiments
involving
43
participants.
In
first
experiment,
showed
4-second
tVNS
trains
reliably
induced
greater
pupil
dilation
compared
to
SHAM
condition,
indicating
increased
activity.
second
applied
during
random
dot
motion
task
assess
impact
on
perceptual
decision-making.
Notably,
improved
accuracy
without
affecting
reaction
times,
which
appears
inconsistent
with
hypothesis.
Drift-diffusion
model
analyses
further
supported
revealing
drift
rate,
indicative
enhanced
evidence
accumulation.
Accuracy
and
drift-rate
improvements
were
especially
pronounced
following
errors
less
proficient
participants,
who
otherwise
exhibited
post-error
declines
these
measures
under
condition.
Our
findings
suggest
influence
adapts
demands,
becoming
beneficial
challenging
contexts.
Overall,
study
underscores
potential
as
non-invasive
tool
investigate
causal
behavior.
Subarachnoid
hemorrhage
(SAH)
is
characterized
by
intense
central
inflammation,
leading
to
substantial
post-hemorrhagic
complications
such
as
vasospasm
and
delayed
cerebral
ischemia.
Given
the
anti-inflammatory
effect
of
transcutaneous
auricular
vagus
nerve
stimulation
(taVNS)
its
ability
promote
brain
plasticity,
taVNS
has
emerged
a
promising
therapeutic
option
for
SAH
patients.
However,
effects
on
cardiovascular
dynamics
in
critically
ill
patients,
like
those
with
SAH,
have
not
yet
been
investigated.
association
between
cardiac
elevated
risk
poor
clinical
outcomes
after
it
essential
characterize
ensure
this
approach
safe
fragile
population.
Therefore,
we
assessed
impact
both
acute
repetitive
function
study.In
randomized
trial,
24
patients
were
assigned
either
treatment
or
Sham
group.
During
their
stay
intensive
care
unit,
monitored
patient
electrocardiogram
(ECG)
readings
vital
signs.
We
compared
long-term
changes
heart
rate,
rate
variability,
QT
interval,
blood
pressure
two
groups.
Additionally,
comparing
metrics
before,
during,
intervention.
also
explored
biomarkers
exhibiting
improvement.We
found
that
did
significantly
alter
pressure,
intracranial
pressure.
increased
overall
variability
parasympathetic
activity
sham
treatment.
The
increase
was
most
pronounced
from
2–4
days
initial
(Cohen’s
d
=
0.50).
Acutely,
peripheral
perfusion
index
without
affecting
corrected
variability.
post-treatment
elevation
more
who
experienced
decrease
than
one
point
Modified
Rankin
Score
at
time
discharge.Our
study
induce
adverse
effects,
bradycardia
prolongation,
supporting
development
immunomodulatory
observed
may
serve
biomarker
could
derive
greater
benefit
treatment.NCT04557618